Impacts of renin–angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents

This study investigated the impacts of renin–angiotensin system inhibitors (RASIs) on 2-year clinical outcomes in diabetes and dyslipidemic acute myocardial infarction (AMI) patients after a successful percutaneous coronary intervention (PCI) using newer-generation drug-eluting stents (DESs). A tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Hoon, Her, Ae-Young, Jeong, Myung Ho, Kim, Byeong-Keuk, Hong, Sung-Jin, Kim, Seunghwan, Ahn, Chul-Min, Kim, Jung-Sun, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387038/
https://www.ncbi.nlm.nih.gov/pubmed/32791710
http://dx.doi.org/10.1097/MD.0000000000021289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387038/
https://www.ncbi.nlm.nih.gov/pubmed/32791710
http://dx.doi.org/10.1097/MD.0000000000021289

Ejemplares similares